http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1209159-B1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24aca9ded2638ea793d05360dde7a4a0 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-14 |
filingDate | 2001-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b49db6c9cd01576fbbb4fdd378a21595 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_021bf9e4fb6f327fd320976eb0b139c3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_90d18c6cb8d2cea248087123223ffbfa |
publicationDate | 2004-11-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | EP-1209159-B1 |
titleOfInvention | Process of preparation of anhydrous mirtazapine crystals |
abstract | Methods for producing anhydrous mirtazapine crystals that are either (1) substantially free of lower alcohol insolubles or (2) substantially free of residual solvent and have an average particle diameter of from 10 to 50 mu m, are provided, and the resulting anhydrous mirtazapine crystals produced thereby, which are useful in pharmaceuticals. |
priorityDate | 2000-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.